Arcus Biosciences, Inc.·4

Jan 20, 4:11 PM ET

Grossman William 4

4 · Arcus Biosciences, Inc. · Filed Jan 20, 2021

Insider Transaction Report

Form 4
Period: 2021-01-19
Grossman William
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2021-01-19+18,75025,477 total
  • Award

    Stock Option (right to buy)

    2021-01-19+112,500112,500 total
    Exercise: $36.73Exp: 2031-01-18Common Stock (112,500 underlying)
Footnotes (2)
  • [F1]Represents the grant of restricted stock units that vest in four equal annual installments after January 1, 2021, subject to the Reporting Person's continued service to the Company.
  • [F2]The option is exercisable in 48 equal monthly installments after January 1, 2021, subject to the Reporting Person's continued service to the Company.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION